IN8bio (INAB) Competitors

$1.60 +0.03 (+1.58%)

As of 12:12 PM Eastern

INAB vs. IZTC, PYRGF, IMA, GRML, and IBIO

Should you be buying IN8bio stock or one of its competitors? The main competitors of IN8bio include Invizyne Technologies (IZTC), PyroGenesis Canada (PYRGF), ImageneBio (IMA), Greenland Mines Ltd. Common Stock (GRML), and iBio (IBIO). These companies are all part of the "pharmaceutical products" industry.

How does IN8bio compare to Invizyne Technologies?

IN8bio (NASDAQ:INAB) and Invizyne Technologies (NASDAQ:IZTC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

: In the previous week, IN8bio had 1 more articles in the media than Invizyne Technologies. MarketBeat recorded 2 mentions for IN8bio and 1 mentions for Invizyne Technologies. IN8bio's average media sentiment score of 0.00 equaled Invizyne Technologies'average media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IN8bio
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Invizyne Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: IN8bio presently has a consensus target price of $4.00, indicating a potential upside of 149.22%. Given IN8bio's stronger consensus rating and higher possible upside, research analysts clearly believe IN8bio is more favorable than Invizyne Technologies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IN8bio
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
Invizyne Technologies
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IN8bio N/A N/A -$19.44M -$4.45 N/A
Invizyne Technologies N/A N/A N/A N/A N/A
: 92.1% of IN8bio shares are held by institutional investors. 14.5% of IN8bio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: Invizyne Technologies' return on equity of 0.00% beat IN8bio's return on equity.
Company Net Margins Return on Equity Return on Assets
IN8bio N/A -111.30% -88.07%
Invizyne Technologies N/A N/A N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IN8bio	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Invizyne Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IN8bio	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Invizyne Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IN8bio	N/A	N/A	-$19.44M	-$4.45	N/A
Invizyne Technologies	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
IN8bio	N/A	-111.30%	-88.07%
Invizyne Technologies	N/A	N/A	N/A

Summary

IN8bio beats Invizyne Technologies on 6 of the 8 factors compared between the two stocks.

How does IN8bio compare to PyroGenesis Canada?

PyroGenesis Canada (NASDAQ:PYRGF) and IN8bio (NASDAQ:INAB) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

: PyroGenesis Canada has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500. Comparatively, IN8bio has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500.
: IN8bio has a consensus price target of $4.00, suggesting a potential upside of 149.22%. Given IN8bio's stronger consensus rating and higher probable upside, analysts clearly believe IN8bio is more favorable than PyroGenesis Canada.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PyroGenesis Canada
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
IN8bio
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: 0.0% of PyroGenesis Canada shares are held by institutional investors. Comparatively, 92.1% of IN8bio shares are held by institutional investors. 47.7% of PyroGenesis Canada shares are held by company insiders. Comparatively, 14.5% of IN8bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: In the previous week, IN8bio had 1 more articles in the media than PyroGenesis Canada. MarketBeat recorded 2 mentions for IN8bio and 1 mentions for PyroGenesis Canada. PyroGenesis Canada's average media sentiment score of 0.00 equaled IN8bio'saverage media sentiment score.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PyroGenesis Canada
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
IN8bio
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: IN8bio has lower revenue, but higher earnings than PyroGenesis Canada. PyroGenesis Canada is trading at a lower price-to-earnings ratio than IN8bio, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PyroGenesis Canada $9.14M 6.86 -$21.12M -$0.05 N/A
IN8bio N/A N/A -$19.44M -$4.45 N/A
: IN8bio has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat IN8bio's return on equity.
Company Net Margins Return on Equity Return on Assets
PyroGenesis Canada -115.14% N/A -60.81%
IN8bio N/A -111.30% -88.07%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
IN8bio	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PyroGenesis Canada	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IN8bio	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PyroGenesis Canada	$9.14M	6.86	-$21.12M	-$0.05	N/A
IN8bio	N/A	N/A	-$19.44M	-$4.45	N/A

Company	Net Margins	Return on Equity	Return on Assets
PyroGenesis Canada	-115.14%	N/A	-60.81%
IN8bio	N/A	-111.30%	-88.07%

Summary

IN8bio beats PyroGenesis Canada on 8 of the 14 factors compared between the two stocks.

How does IN8bio compare to ImageneBio?

ImageneBio (NASDAQ:IMA) and IN8bio (NASDAQ:INAB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

: ImageneBio presently has a consensus price target of $26.50, suggesting a potential upside of 342.33%. IN8bio has a consensus price target of $4.00, suggesting a potential upside of 149.22%. Given ImageneBio's higher possible upside, equities research analysts plainly believe ImageneBio is more favorable than IN8bio.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ImageneBio
2 Sell rating(s)
1 Hold rating(s)

0 Buy rating(s)

1 Strong Buy rating(s)
2.00
IN8bio
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: IN8bio has lower revenue, but higher earnings than ImageneBio. ImageneBio is trading at a lower price-to-earnings ratio than IN8bio, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ImageneBio $800K 79.76 -$45.35M -$8.07 N/A
IN8bio N/A N/A -$19.44M -$4.45 N/A
: In the previous week, IN8bio had 2 more articles in the media than ImageneBio. MarketBeat recorded 2 mentions for IN8bio and 0 mentions for ImageneBio. ImageneBio's average media sentiment score of 0.00 equaled IN8bio'saverage media sentiment score.
Company Overall Sentiment
ImageneBio Neutral
IN8bio Neutral
: ImageneBio has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Comparatively, IN8bio has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500.
: 75.0% of ImageneBio shares are owned by institutional investors. Comparatively, 92.1% of IN8bio shares are owned by institutional investors. 5.9% of ImageneBio shares are owned by insiders. Comparatively, 14.5% of IN8bio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: ImageneBio's return on equity of -35.77% beat IN8bio's return on equity.
Company Net Margins Return on Equity Return on Assets
ImageneBio N/A -35.77% -31.78%
IN8bio N/A -111.30% -88.07%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ImageneBio	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.00
IN8bio	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ImageneBio	$800K	79.76	-$45.35M	-$8.07	N/A
IN8bio	N/A	N/A	-$19.44M	-$4.45	N/A

Company	Overall Sentiment
ImageneBio	Neutral
IN8bio	Neutral

Company	Net Margins	Return on Equity	Return on Assets
ImageneBio	N/A	-35.77%	-31.78%
IN8bio	N/A	-111.30%	-88.07%

Summary

IN8bio beats ImageneBio on 7 of the 13 factors compared between the two stocks.

How does IN8bio compare to Greenland Mines Ltd. Common Stock?

IN8bio (NASDAQ:INAB) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

: Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than IN8bio, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IN8bio N/A N/A -$19.44M -$4.45 N/A
Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A
: IN8bio's return on equity of -111.30% beat Greenland Mines Ltd. Common Stock's return on equity.
Company Net Margins Return on Equity Return on Assets
IN8bio N/A -111.30% -88.07%
Greenland Mines Ltd. Common Stock N/A -137.58% -126.00%
: In the previous week, Greenland Mines Ltd. Common Stock had 3 more articles in the media than IN8bio. MarketBeat recorded 5 mentions for Greenland Mines Ltd. Common Stock and 2 mentions for IN8bio. IN8bio's average media sentiment score of 0.00 beat Greenland Mines Ltd. Common Stock's score of 0.00 indicating that IN8bio is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IN8bio
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Greenland Mines Ltd. Common Stock
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: IN8bio currently has a consensus price target of $4.00, indicating a potential upside of 149.22%. Given IN8bio's stronger consensus rating and higher possible upside, equities research analysts plainly believe IN8bio is more favorable than Greenland Mines Ltd. Common Stock.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IN8bio
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
Greenland Mines Ltd. Common Stock
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: IN8bio has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 7.61, suggesting that its stock price is 661% more volatile than the S&P 500.
: 92.1% of IN8bio shares are owned by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. 14.5% of IN8bio shares are owned by company insiders. Comparatively, 9.9% of Greenland Mines Ltd. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IN8bio	N/A	N/A	-$19.44M	-$4.45	N/A
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A

Company	Net Margins	Return on Equity	Return on Assets
IN8bio	N/A	-111.30%	-88.07%
Greenland Mines Ltd. Common Stock	N/A	-137.58%	-126.00%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IN8bio	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IN8bio	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

IN8bio beats Greenland Mines Ltd. Common Stock on 9 of the 13 factors compared between the two stocks.

How does IN8bio compare to iBio?

iBio (NASDAQ:IBIO) and IN8bio (NASDAQ:INAB) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

: 7.9% of iBio shares are held by institutional investors. Comparatively, 92.1% of IN8bio shares are held by institutional investors. 2.8% of iBio shares are held by insiders. Comparatively, 14.5% of IN8bio shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
: iBio currently has a consensus target price of $4.75, indicating a potential upside of 181.90%. IN8bio has a consensus target price of $4.00, indicating a potential upside of 149.22%. Given iBio's stronger consensus rating and higher possible upside, equities research analysts plainly believe iBio is more favorable than IN8bio.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iBio
1 Sell rating(s)
0 Hold rating(s)

2 Buy rating(s)

3 Strong Buy rating(s)
3.17
IN8bio
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: In the previous week, IN8bio had 1 more articles in the media than iBio. MarketBeat recorded 2 mentions for IN8bio and 1 mentions for iBio. iBio's average media sentiment score of 1.66 beat IN8bio's score of 0.00 indicating that iBio is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iBio
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
IN8bio
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: iBio's return on equity of -71.26% beat IN8bio's return on equity.
Company Net Margins Return on Equity Return on Assets
iBio N/A -71.26% -57.92%
IN8bio N/A -111.30% -88.07%
: iBio has higher revenue and earnings than IN8bio. iBio is trading at a lower price-to-earnings ratio than IN8bio, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
iBio $400K 152.24 -$18.38M -$1.00 N/A
IN8bio N/A N/A -$19.44M -$4.45 N/A
: iBio has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Comparatively, IN8bio has a beta of 0.08, suggesting that its share price is 92% less volatile than the S&P 500.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iBio	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	3 Strong Buy rating(s)	3.17
IN8bio	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iBio	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
IN8bio	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
iBio	N/A	-71.26%	-57.92%
IN8bio	N/A	-111.30%	-88.07%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iBio	$400K	152.24	-$18.38M	-$1.00	N/A
IN8bio	N/A	N/A	-$19.44M	-$4.45	N/A

Summary

iBio beats IN8bio on 11 of the 15 factors compared between the two stocks.

Get IN8bio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INAB vs. The Competition

Export

Metric	IN8bio	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$15.80M	$3.38B	$6.24B	$12.17B
Dividend Yield	N/A	2.23%	2.74%	5.26%
P/E Ratio	-0.36	35.24	28.59	27.34
Price / Sales	N/A	304.27	536.59	84.45
Price / Cash	N/A	125.30	43.35	54.56
Price / Book	0.57	7.17	9.92	6.87
Net Income	-$19.44M	$23.57M	$3.54B	$332.89M
7 Day Performance	9.18%	2.77%	1.64%	2.29%
1 Month Performance	12.24%	6.24%	5.96%	9.08%
1 Year Performance	-67.18%	78.71%	42.95%	43.73%

IN8bio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INAB IN8bio	2.1129 of 5 stars	$1.61 +1.6%	$4.00 +149.2%	-68.1%	$15.80M	N/A	N/A	20	News Coverage
IZTC Invizyne Technologies	N/A	$9.75 -2.3%	N/A	-8.9%	$60.96M	N/A	N/A	29
PYRGF PyroGenesis Canada	N/A	$0.29 flat	N/A	-7.2%	$60.89M	$9.14M	N/A	90	Gap Down
IMA ImageneBio	1.7102 of 5 stars	$5.71 -0.2%	$26.50 +364.1%	-55.2%	$60.81M	$800K	N/A	70
GRML Greenland Mines Ltd. Common Stock	0.1053 of 5 stars	$0.49 +2.1%	N/A	+179.7%	$59.41M	N/A	N/A	5	News Coverage Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INAB) was last updated on 5/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IN8bio (INAB) Competitors

INAB vs. IZTC, PYRGF, IMA, GRML, and IBIO

How does IN8bio compare to Invizyne Technologies?

Summary

How does IN8bio compare to PyroGenesis Canada?

Summary

How does IN8bio compare to ImageneBio?

Summary

How does IN8bio compare to Greenland Mines Ltd. Common Stock?

Summary

How does IN8bio compare to iBio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INAB vs. The Competition

IN8bio Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IN8bio (INAB) Competitors

INAB vs. IZTC, PYRGF, IMA, GRML, and IBIO

How does IN8bio compare to Invizyne Technologies?

Summary

How does IN8bio compare to PyroGenesis Canada?

Summary

How does IN8bio compare to ImageneBio?

Summary

How does IN8bio compare to Greenland Mines Ltd. Common Stock?

Summary

How does IN8bio compare to iBio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INAB vs. The Competition

IN8bio Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools